Here the gain-of-function hotspot mutant p53 R248Q mouse model, which primarily develops T-lymphomas, provided proof-of-principal that the Hsp90 inhibitor ganetespib potentiates the antineoplastic efficacy of CTX by suppressing autochthonous tumor growth and prolonging PFS and OS. Here, TP53 is linked to lymphoma.